Comments

Avidity Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Avidity Biosciences (RNA) operate in?

Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RNANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Avidity Biosciences (RNA) Forecast

News Earnings Avidity Biosciences (RNA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Avidity Biosciences Stock Price, Quotes and Forecasts | NASDAQ:RNA | Benzinga

Explore Avidity Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNA.

Open	$31.79
Close	-
Volume / Avg.	119.89K / 1.32M
Day Range	$31.73 - $32.75
52 Wk Range	21.56 - 56.00
Market Cap	$3.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	16.52%
Days to Cover	12.57

Recent News

Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025

Avidity's del-zota met key Phase 1/2 trial goals in DMD44, shows strong exon skipping, dystrophin restoration and creatine kinase reduction.

Vandana Singh

Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks

BMO Capital Markets initiates coverage on Dyne Therapeutics with an Outperform rating, an $84 target, and a projected $4.3 billion peak sales for DYNE-101.

Vandana Singh

This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$31.79
Close	-
Volume / Avg.	119.89K / 1.32M
Day Range	$31.73 - $32.75
52 Wk Range	21.56 - 56.00
Market Cap	$3.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	16.52%
Days to Cover	12.57

About Avidity Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Avidity Biosciences (RNA) stock?

You can purchase shares of Avidity Biosciences (NASDAQ:RNA) through any online brokerage.

View our list of the best stock brokerages

Who are Avidity Biosciences (RNA) competitors?

Other companies in Avidity Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for Avidity Biosciences (RNA) stock?

Avidity Biosciences has a consensus price target of $60.44.

What is the current price for Avidity Biosciences (RNA)?

The stock price for Avidity Biosciences (NASDAQ: RNA) is $32.12 last updated March 26, 2025 at 10:05 AM EDT.

Does Avidity Biosciences (RNA) pay a dividend?

There are no upcoming dividends for Avidity Biosciences.

When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?

Avidity Biosciences’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Avidity Biosciences (RNA) going to split?

There is no upcoming split for Avidity Biosciences.

What sector and industry does Avidity Biosciences (RNA) operate in?

Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.